[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100651332":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":29,"responsibleParty":46,"collaborators":18,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":18,"enrollmentInfo":57,"targetDuration":18,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":18,"overallStatus":66,"whyStopped":18,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Versailles Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention arm","EXPERIMENTAL","Integration of a digital tool into the follow-up care of patients with CML who have been off treatment for up to 2 years.",[13],"Other: Integration of a digital tool",[15],{"type":6,"name":16,"description":11,"armGroupLabels":17,"otherNames":18},"Integration of a digital tool",[9],null,[20],{"name":21,"affiliation":5,"role":22},"Cindy JAFFRY","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":18,"email":28},"Laure Morisset","CONTACT","+33139239785","lmorisset@ght78sud.fr",[30],{"facility":31,"status":18,"city":32,"state":18,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"CH de Versailles","Le Chesnay","78150","France","FR",{"type":37,"coordinates":38},"Point",[39,40],2.12213,48.8222,{"lat":40,"lon":39},[43],{"name":44,"role":26,"phone":45,"phoneExt":18,"email":28},"Laure MORISSET","0139239785",{"type":22,"investigatorFullName":21,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Principal investigator","100651332","feasibility-study-to-evaluate-a-digital-tool-for-monitoring-patients-who-have-discontinued-treatment-for-chronic-myeloid-leukemia-100651332",false,"NCT07760311","Feasibility Study to Evaluate a Digital Tool for Monitoring Patients Who Have Discontinued Treatment for Chronic Myeloid Leukemia","FREE CML","Inclusion Criteria:\n\n* Patients aged 18 or older\n* Patients with chronic myeloid leukemia who have been off treatment for ≤ 2 years\n* Patients with access to a digital device with internet access\n* Be enrolled in the social security system\n* Have given verbal consent after reviewing the study information sheet\n\nExclusion Criteria:\n\n* Patients who cannot read or understand French;\n* Individuals entitled to enhanced protection, namely minors, individuals deprived of their liberty by a judicial or administrative decision, individuals staying in a health or social care facility, adults under legal guardianship, and, finally, patients in emergency situations","ALL","18 Years",{"count":58,"type":59},20,"ESTIMATED","INTERVENTIONAL",[62],"NA","The objective of this project is to evaluate, over a 12-month period, the feasibility of integrating a digital tool into the follow-up care of patients with chronic myeloid leukemia who have been off treatment for up to 2 years. Feasibility will be assessed based on the usage rate, defined as the proportion of patients who accessed the digital tool at least:\n\n* once a month, if treatment discontinuation was ≤ 6 months;\n* once a quarter, if treatment discontinuation was \\> 6 months. The usage rate will be assessed and compared to a threshold of 60%; if the rate falls below this threshold, feasibility will be considered insufficient.",[65],"Chronic Leukemia","NOT_YET_RECRUITING","2026-08-07",{"date":69,"type":70},"2026-08-12","ACTUAL",{"date":72,"type":59},"2026-09-15",{"date":74,"type":59},"2028-09-30",{"name":5,"class":6},1]